• 1
    Lee YA, Wahn U, Kehrt R et al. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet 2000; 26: 4703.
  • 2
    Cookson WO, Ubhi B, Lawrence R et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 2001; 27: 3723.
  • 3
    Cox HE, Moffatt MF, Faux JA, Walley AJ, Coleman R, Trembath RC, Cookson WO, Harper JI. Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor. Br J Dermatol 1998; 138: 1827.
  • 4
    Kawashima T, Noguchi E, Arinami T, Yamakawa-Kobayashi K, Nakagawa H, Otsuka F, Hamaguchi H. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med 1998; 35: 5024.
  • 5
    He JQ, Chan-Yeung M, Becker AB, Dimwit-Ward H, Ferguson AC, Manfreda J, Watson WT, Sandford AJ. Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun 2003; 4: 3859.
  • 6
    Liu X, Nickel R, Beyer K et al. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol 2000; 106: 16770.
  • 7
    Nickel RG, Casolaro V, Wahn U et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 2000; 164: 16126.
  • 8
    Nishio Y, Noguchi E, Ito S, Ichikawa E, Umebayashi Y, Otsuka F, Arinami T. Mutation and association analysis of the interferon regulatory factor 2 gene (IRF2) with atopic dermatitis. J Hum Genet 2001; 46: 6647.
  • 9
    Weidinger S, Klopp N, Rummler L et al. Association of NOD1 polymorphisms with atopic eczema and related phenotypes. J Allergy Clin Immunol 2005; 116: 17784.
  • 10
    Kabesch M, Peters W, Carr D, Leupold W, Weiland SK, Von Mutius E. Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations. J Allergy Clin Immunol 2003; 111: 8137.
  • 11
    Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K et al. The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 2004; 113: 5657.
  • 12
    Ring J, Kramer U, Schafer T, Behrendt H. Why are allergies increasing? Curr Opin Immunol 2001; 13: 7018.
  • 13
    Williams HC, Strachan DP, Hay RJ. Childhood eczema: disease of the advantaged? Br Med 1994; 308: 11325.
  • 14
    Strachan DP. Hay fever, hygiene and household size. Br Med 1989; 299: 125960.
  • 15
    Matricardi PM, Bonini S. High microbial turnover rate preventing atopy: a solution to inconsistencies impinging on the Hygiene hypothesis? Clin Exp Allergy 2000; 30: 150610.
  • 16
    Yazdanbakhsh M, Kremsner PG, Van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002; 296: 4904.
  • 17
    Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunol 2004; 112: 35263.
  • 18
    Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergic development and the intestinal micro-flora during the first year of life. J Allergy Clin Immunol 2001; 108: 51620.
  • 19
    Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tajiri Y, Kumemura M. Differences in faecal micro-flora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 2003; 111: 58791.
  • 20
    Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the ‘hygiene hypothesis’: too clean to be true? Br J Dermatol 2005; 152: 20216.
  • 21
    Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357: 10769.
  • 22
    Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99: 17985.
  • 23
    Smits HH, Engering A, Van Der Kleij D et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005; 115: 12607.
  • 24
    Lubbe J. Secondary infections in patients with atopic dermatitis. Am J Clin Dermatol 2003; 4: 64154.
  • 25
    Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974; 90: 52530.
  • 26
    Ring J, Abeck D, Neuber K. Atopic eczema: role of microorganisms on the skin surface. Allergy 1992; 47: 2659.
  • 27
    Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 1992; 27: 2934.
  • 28
    Guzik TJ, Bzowska M, Kasprowicz A, Czerniawska-Mysik G, Wójcik K, Szmyd D, Adamek-Guzik T, Pryjma J. Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clin Exp Allergy 2005; 35: 44855.
  • 29
    Rippke F, Schreiner V, Doering T, Maibach HI. Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus aureus. Am J Clin Dermatol 2004; 5: 21723.
  • 30
    Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Ichikawa Y, Imokawa G. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 2002; 119: 4339.
  • 31
    Cho SH, Strickland I, Tomkinson A, Fehringer AP, Gelfand EW, Leung DY. Preferential binding of Staphylococcus aureus to skin sites of Th-2 mediated inflammation in a murine model. J Invest Dermatol 2001; 116: 65863.
  • 32
    Al-Mohanna F, Parhar R, Kawaasi A, Ernst P, Sheth K, Harfi H, Al-Sedairy S. Inhibition of neutrophil functions by human immunoglobulin E. J Allergy Clin Immunol 1993; 92: 57566.
  • 33
    Gallo RL, Murakami M, Ohtake T, Zaiou M. Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol 2002; 110: 82331.
  • 34
    Schroder J-M, Harder J. Human beta-defensin-2. Int J Biochem Cell Biol 1999; 31: 64551.
  • 35
    Harder J, Bartels J, Christophers E, Schroder J-M. Isolation and characterisation of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276: 570713.
  • 36
    Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leuk Biol 2004; 75: 3948.
  • 37
    Biragyn A, Ruffini PA, Leifer CA et al. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 2002; 298: 102559.
  • 38
    Yang D, Chertov O, Bykovskaia SN et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999; 286: 5258.
  • 39
    Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347: 115160.
  • 40
    Nomura I, Goleva E, Howell MD et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003; 171: 32629.
  • 41
    Rieg S, Steffen H, Seeber S, Humeny A, Kalbacher H, Dietz K, Garbe C, Schittek B. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 2005; 174: 800310.
  • 42
    Schittek B, Hipfel R, Sauer B et al. Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol 2001; 2: 11337.
  • 43
    Stern UM, Hornstein OP, Salzer B. Do training-dependent differences in perspiration exist between healthy and atopic subjects? J Dermatol 2000; 27: 4919.
  • 44
    Imayama S, Shimozono Y, Hoashi M, Yasumoto S, Ohta S, Yoneyama K, Hori Y. Reduced secretion of IgA to skin surface of patients with atopic dermatitis. J Allergy Clin Immunol 1994; 94: 195200.
  • 45
    Travassos LH, Girardin SE, Philpott DJ, Blanot D, Nahori MA, Werts C, Boneca IG. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Reports 2004; 5: 10006.
  • 46
    Takeda K, Akira S. Toll-like receptors in innate immunity. Int. Immunol 2005; 17: 114.
  • 47
    Pivarcsi A, Nagy I, Kemeny L. Innate immunity in the skin: how keratinocytes fight against pathogens. Curr Immunol Rev 2005; 1: 2942.
  • 48
    Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Int Med 2002; 162: 102832.
  • 49
    Girardin SE, Hugot J-P, Sansonetti PJ. Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing. Trends Immunol 2003; 24: 6528.
  • 50
    Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599603.
  • 51
    Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 6036.
  • 52
    Matsubara M, Harada D, Manabe H, Hasegawa K. Staphylococcus aureus peptidoglycan stimulates granulocyte macrophage colony-stimulating factor production from human epidermal keratinocytes via mitogen-activated protein kinases. FEBS Lett 2004; 566: 195200.
  • 53
    Proft T, Fraser JD. Bacterial superantigens. Clin Exp Immunol 2003; 133: 299306.
  • 54
    Strange P, Skov L, Lisby S, Nielsen PL, Baadsgaard O. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996; 132: 2733.
  • 55
    Michie CA, Davie T. Atopic dermatitis and staphylococcal superantigens. Lancet 1996; 347: 324.
  • 56
    Skov L, Olsen JV, Giorno R, Schlievert PM, Baadsgaard O, Leung DY. Application of Staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism. J Allergy Clin Immunol 2000; 105: 8206.
  • 57
    Davison S, Allen M, Vaughan R, Barker J. Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vbeta-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes. Clin Exp Immunol 2000; 121: 1816.
  • 58
    Leung DY, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med 1995; 181: 74753.
  • 59
    Ou LS, Goleva E, Hall C, Leung DY. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 2004; 113: 75663.
  • 60
    Lin Y-T, Wang CT, Hsu CT, Wang LF, Shau WY, Yang YH, Chang BL. Differential susceptibility to Staphylococcal superantigen (SsAg)-induced apoptosis of CD4+ T cells from atopic dermatitis patients and healthy subjects: The inhibitory effect of IL-4 on SsAg-induced apoptosis. J Immunol 2003; 171: 11028.
  • 61
    Leiferman KM, Ackerman SJ, Sampson HA, Haugen HS, Venencie PY, Gleich GJ. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. N Engl J Med 1985; 313: 2825.
  • 62
    Maeda K, Yamamoto K, Tanaka Y, Anan S, Yoshida H. The relationship between eosinophils, OKT6-positive cells and house dust mite (HDM) antigens in naturally occurring lesions of atopic dermatitis. J Dermatol Sci 1992; 3: 1516.
  • 63
    Morishita Y, Tada J, Sato A, Toi Y, Kanzaki H, Akiyama H, Arata J. Possible influences of Staphylococcus aureus on atopic dermatitis – the colonizing features and the effects of staphylococcal enterotoxins. Clin Exp Allergy 1999; 29: 11107.
  • 64
    Wedi B, Wieczorek D, Stunkel T, Breuer K, Kapp A. Staphylococcal exotoxins exert proinflammatory effects through inhibition of eosinophil apoptosis, increased surface antigen expression (CD11b, CD45, CD54, and CD69), and enhanced cytokine-activated oxidative burst, thereby triggering allergic inflammatory reactions. J Allergy Clin Immunol 2002; 109: 47784.
  • 65
    Wakita H, Tokura Y, Furukawa F, Takigawa M. Staphylococcal enterotoxin B upregulates expression of ICAM-1 molecules on IFN-gamma-treated keratinocytes and keratinocyte cell lines. J Invest Dermatol 1995; 105: 53642.
  • 66
    Ezepchuk YV, Leung DY, Middleton MH, Bina P, Rieser R, Norris DA. Staphylococcal toxins and protein A induce cytotoxicity and release of tumor necrosis factor from human keratinocytes. J Invest Dermatol 1996; 107: 6039.
  • 67
    Goodman RE, Nestle F, Naidu YM, Green JM, Thompson CB, Nickoloff BJ, Turka LA. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma. J Immunol 1994; 152: 518998.
  • 68
    Travers JB, Norris DA, Leung DYM. The keratinocyte as a target for staphylococcal bacterial toxins. J Invest Dermatol Symp Proc 2001; 6: 22530.
  • 69
    Leung DY, Harbeck R, Bina P, Reiser RF, Yang E, Norris DA, Hanifin JM, Sampson HA. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. J Clin Invest 1993; 92: 137480.
  • 70
    Nissen D, Pedersen LJ, Skov PS, Vejlsgaard GL, Poulsen LK, Jarlov JO, Karlsmark T, Nolte H. IgE-binding components of staphylococcal enterotoxins in patients with atopic dermatitis. Ann Allergy Asthma Immunol 1997; 79: 4038.
  • 71
    Mrabet-Dahbi S, Breuer K, Klotz M, Herz U, Heeg K, Werfel T, Renz H. Deficiency in immunoglobulin G2 antibodies against staphylococcal enterotoxin C1 defines a subgroup of patients with atopic dermatitis. Clin Exp Allergy 2005; 35: 27481.
  • 72
    Bredius RG, De Vries CE, Troelstra A, Van Alphen L, Weening RS, Van De Winkel JG, Out TA. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2. J Immunol 1993; 151: 146372.
  • 73
    Scheynius A, Johansson C, Buentke E, Zargari A, Linder MT. Atopic eczema/dermatitis syndrome and Malassezia. Int Arch Allergy Immunol 2002; 127: 1619.
  • 74
    Devos SA, Van Der Valk PG. The relevance of skin prick tests for Pityrosporum ovale in patients with head and neck dermatitis. Allergy 2000; 55: 10568.
  • 75
    Scalabrin DM, Bavbek S, Perzanowski MS, Wilson BB, Platts-Mills TA, Wheatley LM. Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis. a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol 1999; 104: 12739.
  • 76
    Broberg A, Faergemann J, Johansson S, Johansson SG, Strannegard IL, Svejgaard E. Pityrosporum ovale and atopic dermatitis in children and young adults. Acta Derm Venereol 1992; 72: 18792.
  • 77
    Kim TY, Jang IG, Park YM, Kim IIO, Kim CW. Head and neck dermatitis: the role of Malassezia furfur, topical steroid use and environmental factors in its causation. Clin Exp Dermatol 1999; 24: 22631.
  • 78
    Nissen D, Petersen LJ, Esch R, Svejgaard E, Skov PS, Poulsen LK, Nolte II. IgE-sensitization to cellular and culture filtrates of fungal extracts in patients with atopic dermatitis. Ann Allergy Asthma Immunol 1998; 81: 24755.
  • 79
    Buentke E, Scheynius A. Dendritic cells and fungi. APMIS 2003; 111: 78996.
  • 80
    Tengvall Linder M, Johansson C, Zargari A, Bengtsson A, Van Der Ploeg I, Jones I, Harfast B, Scheynius A. Detection of Pityrosporum orbiculare reactive T cells from skin and blood in atopic dermatitis and characterisation of their cytokine profiles. Clin Exp Allergy 1996; 26: 128697.
  • 81
    Johansson C, Eshagi H, Linder MT, Jakobson E, Scheynius A. Positive atopy patch test reaction to Malassezia furfur in atopic dermatitis correlates with a T helper 2-like peripheral blood mononuclear cell response. J Invest Dermatol 2002; 118: 104451.
  • 82
    Belew PW, Rosenberg EW, Jennings BR. Activation of the alternative pathway of complement by Malassezia ovalis (Pityrosporum ovale). Mycopathologica 1980; 70: 18790.
  • 83
    Watnabe S, Kano R, Sato II, Nakamura Y, Ilasegawa A. The effects of Malassezia yeasts on cytokine production by human keratinocytes. J Invest Dermatol 2001; 116: 76973.
  • 84
    Aspres N, Anderson C. Malassezia yeasts in the pathogenesis of atopic dermatitis. Austr J Dermatol 2004; 45: 199207.
  • 85
    Leung T-f, Tang NLS, Wong GWK, Fok T-f. CD14 and Toll-like receptors: Potential contribution of genetic factors and mechanisms to inflammation and allergy. Curr Drug Targets – Inflamm Allergy 2005; 4: 16975.